133 related articles for article (PubMed ID: 24078409)
1. Moderate to severe nausea in radioactive iodine (RAI) therapy is associated with the RAI dose per body weight and was not prevented by ramosetron.
Ikeoka T; Ando T; Imaizumi M; Ueki I; Usa T; Kawakami A
Endocrine; 2014 May; 46(1):131-7. PubMed ID: 24078409
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting.
Ho CL; Su WC; Hsieh RK; Lin ZZ; Chao TY
Jpn J Clin Oncol; 2010 Apr; 40(4):294-301. PubMed ID: 20026457
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.
Yano S; Makino K; Nakamura H; Kai Y; Morioka M; Hamada J; Kochi M; Kuratsu J
Neurol Med Chir (Tokyo); 2005 Jun; 45(6):294-8; discussion 298-9. PubMed ID: 15973062
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
5. Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Jpn J Clin Oncol; 2009 Feb; 39(2):111-5. PubMed ID: 19060294
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy.
Fujii Y; Tanaka H
Clin Ther; 2002 Jul; 24(7):1148-53. PubMed ID: 12182258
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement.
Hahm TS; Ko JS; Choi SJ; Gwak MS
Anaesthesia; 2010 May; 65(5):500-4. PubMed ID: 20337618
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy.
Fujii Y; Tanaka H; Somekawa Y
Int J Obstet Anesth; 2004 Jan; 13(1):15-8. PubMed ID: 15321434
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial.
Fujii Y; Uemura A; Tanaka H
Eur J Surg; 2002; 168(11):583-6. PubMed ID: 12699092
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
Kim SI; Kim SC; Baek YH; Ok SY; Kim SH
Br J Anaesth; 2009 Oct; 103(4):549-53. PubMed ID: 19700442
[TBL] [Abstract][Full Text] [Related]
11. Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study.
Kim KM; Huh J; Lee SK; Park EY; Lee JM; Kim HJ
BMC Anesthesiol; 2017 May; 17(1):65. PubMed ID: 28525981
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of granisetron versus ramosetron for nausea and vomiting after breast surgery: a randomized, double-blinded, placebo-controlled trial.
Fujii Y; Tanaka H; Kawasaki T
Am J Ther; 2004; 11(4):278-82. PubMed ID: 15266219
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis.
Yokoi A; Mihara T; Ka K; Goto T
PLoS One; 2017; 12(10):e0186006. PubMed ID: 28977021
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Takenaka M; Okamoto Y; Ikeda K; Hashimoto R; Ueda T; Kurokawa N; Takagi T; Uejima E
Gan To Kagaku Ryoho; 2007 Mar; 34(3):403-7. PubMed ID: 17353632
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ramosetron with combined ramosetron and midazolam for preventing postoperative nausea and vomiting in patients at high risk following laparoscopic gynaecological surgery.
Park EY; Lee SK; Kang MH; Lim KJ; Kim YS; Choi E; Park YH
J Int Med Res; 2013 Jun; 41(3):654-63. PubMed ID: 23660085
[TBL] [Abstract][Full Text] [Related]
16. Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignancies.
Zeng XY; Wang AH; Liu YF; Chen Y; Shen Y; Shen ZX
Methods Find Exp Clin Pharmacol; 2001 May; 23(4):191-5. PubMed ID: 11676227
[TBL] [Abstract][Full Text] [Related]
17. Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy.
Fujii Y; Tanaka H
Clin Ther; 2002 May; 24(5):766-72. PubMed ID: 12075944
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.
Matsui R; Suzuki K; Takiguchi T; Nishio M; Koike T; Hayashi T; Seto T; Kogure Y; Nogami N; Fujiwara K; Kaneda H; Harada T; Shimizu S; Kimura M; Kenmotsu H; Shimokawa M; Goto K
BMC Pharmacol Toxicol; 2020 Oct; 21(1):72. PubMed ID: 33023657
[TBL] [Abstract][Full Text] [Related]
19. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anti-emetic action of domperidone.
Wilson DB; Dundee JW
Anaesthesia; 1979 Sep; 34(8):765-7. PubMed ID: 525733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
